Changes of synovial fluid protein concentrations in supra-patellar bursitis patients after the injection of different molecular weights of hyaluronic acid
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Name:
1-s2.0-S053155651400028X-main.pdf
Size:
279.2Kb
Format:
PDF
Description:
final version
Authors
Chen, Carl P.C.Hsu, Chin Chin
Pei, Yu-Cheng
Chen, Ruoli
Zhou, Shaobo
Shen, Hsuan-Chen
Lin, Shih-Cherng
Tsai, Wen-Chung
Issue Date
2014-01-30Subjects
supra-patellar bursitisWestern immunoblotting
biomarkers
osteoarthritis
protein
viscosupplementation
hyaluronic acid
Metadata
Show full item recordAbstract
Knee pain is commonly seen in orthopedic and rehabilitation outpatient clinical settings, and in the aging population. Bursitis of the knee joint, especially when the volume of the synovial fluid is large enough, can compress and distend the nearby soft tissues, causing pain in the knee joint. Out of all the bursae surrounding the knee joint, supra-patellar bursitis is most often associated with knee pain. Treatment strategies in managing supra-patellar bursitis include the aspiration of joint synovial fluid and then followed by steroid injection into the bursa. When supra-patellar bursitis is caused by degenerative disorders, the concept of viscosupplementation treatment may be effective by injecting hyaluronic acid into the bursa. However, the rheology or the changes in the concentrations of proteins (biomarkers) that are related to the development of bursitis in the synovial fluid is virtually unexplored. Therefore, this study aimed to identify the concentration changes in the synovial fluid total protein amount and individual proteins associated with supra-patellar bursitis using the Bradford protein assay and western immunoglobulin methods. A total of 20 patients were divided into two groups with 10 patients in each group. One group received the high molecular weight hyaluronic acid product of Synvisc Hylan G-F 20 and the other group received the low molecular weight hyaluronic acid product of Hya-Joint Synovial Fluid Supplement once per week injection into the bursa for a total of 3. weeks. Significant decreases in the synovial fluid total protein concentrations were observed after the second dosage of high molecular weight hyaluronic acid injections. Apolipoprotein A-I, interleukin 1 beta, alpha 1 antitrypsin, and matrix metalloproteinase 1 proteins revealed a trend of decreasing western immunoblotting band densities after hyaluronic acid injections. The decreases in apolipoprotein A-I and interleukin 1 beta protein band densities were significant in the high molecular weight hyaluronic acid injection group. Transthyretin, complement 5, and matrilin 3 proteins revealed a trend of increasing western immunoblotting band densities after hyaluronic acid injections. Transthyretin revealed significant increases in protein band densities in both the high and low molecular weight hyaluronic acid injection groups. This study may provide the rationale for targeting several biomarkers associated with lipid transport, inflammation, and anti-aging as possible disease modifying therapies for the treatment of supra-patellar bursitis and even degenerative joint disorders. © 2014 Elsevier B.V.Citation
Chen C, Hsu C, Pei Y, Chen R, Zhou S, Shen H, Lin S, Tsai W (2014) 'Changes of synovial fluid protein concentrations in supra-patellar bursitis patients after the injection of different molecular weights of hyaluronic acid', Experimental Gerontology, 52, pp.30-35.Publisher
ElsevierJournal
Experimental GerontologyPubMed ID
24487346Additional Links
https://www.sciencedirect.com/science/article/pii/S053155651400028XType
ArticleLanguage
enISSN
0531-5565ae974a485f413a2113503eed53cd6c53
10.1016/j.exger.2014.01.016